From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement
News & Literature Highlights

Journal of Cancer Policy

Health-Related Quality of Life Data Collected in Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Clinical Trials

Blood

Response to SARS-CoV-2 Vaccination in Patients After Hematopoietic Cell Transplantation and CAR T-Cell Therapy

Nature Reviews Clinical Oncology

Preparing for CAR T Cell Therapy: Patient Selection, Bridging Therapies and Lymphodepletion

Expert Opinion on Investigational Drugs

CAR-T Cell Therapy for Triple-Negative Breast Cancer and Other Solid Tumors: Preclinical and Clinical Progress

Nature Medicine

Gut Microbiome Correlates of Response and Toxicity Following Anti-CD19 CAR T Cell Therapy

Transplantation and Cellular Therapy

Change in Neurocognitive Performance Among Patients With Non-Hodgkin’s Lymphoma in the First Year After CAR T-Cell Therapy

Blood Cancer Discovery

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation

American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States

JAMA Oncology

Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome

Frontiers in Oncology

In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy

Advertisement
Advertisement